https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Pharmaceuticals-Reports-Positive-Topline-Data-from-Phase-III-Trial-of-LINZESS-linaclotide-in-Pediatric-Patients-Aged-6-17-with-Functional-Constipation/default.aspx